Intrathecal Drug Delivery (IDD)

The successes and future promise of neuromodulation have never been greater. But the threats to patient access are real.

We need patients and caregivers who have benefited from neuromodulation therapies to advocate for appropriate access. Click on the links below to learn more about priority advocacy initiatives and how can you can make a difference.  Join us!

Priority Advocacy Issues

ACOEM Guidelines and Workers' Compensation

New York Call to Action!

Health Technology Assessments

Washington State HTA Reform